KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Axt (AXTI) Research & Development (2016 - 2025)

Axt's Research & Development history spans 15 years, with the latest figure at $1.0 million for Q3 2025.

  • For Q3 2025, Research & Development fell 70.54% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $10.8 million, down 18.45%, while the annual FY2024 figure was $14.5 million, 20.38% up from the prior year.
  • Research & Development for Q3 2025 was $1.0 million at Axt, down from $2.5 million in the prior quarter.
  • Across five years, Research & Development topped out at $4.1 million in Q4 2024 and bottomed at $1.0 million in Q3 2025.
  • The 5-year median for Research & Development is $3.1 million (2025), against an average of $3.0 million.
  • The largest annual shift saw Research & Development surged 70.93% in 2021 before it tumbled 70.54% in 2025.
  • A 5-year view of Research & Development shows it stood at $2.8 million in 2021, then soared by 32.83% to $3.7 million in 2022, then decreased by 22.99% to $2.8 million in 2023, then soared by 46.56% to $4.1 million in 2024, then plummeted by 75.49% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for AXTI's Research & Development are $1.0 million (Q3 2025), $2.5 million (Q2 2025), and $3.1 million (Q1 2025).